BACKGROUND: Recently the parenteral transmission of hepatitis G virus (HGV)
has been shown, The aim of the study was to investigate the incidence of p
ost-transfusion HGV,
PATIENTS AND METHODS: HGV (RNA-HGV and anti-HGVE2) were retrospectively stu
died in 140 transfused patients. RESULTS: 12 (8,6%) were infected after tra
nsfusion: 9 of 12 (75%) the RNA-HGV remained detectable after 6 months and
3 (25%) seroconverted to anti-HGVE2. No patient had post-transfusional hepa
titis criteria, In 5 (42%) the transaminases levels were slighty increased.
The clinical evolution was favourable. No significant differences were fou
nd between patients with or without HGV infection
CONCLUSION: HGV is an agent associated with transfusion but it carries a lo
w pathogenic capability.